Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone

The aim of the study was to examine the influence of overall treatment time (OTT) on the value of calculated biological effective doses (BEDs) for different biological variables. These variables were: tumour proliferation rate, different cell radiosensitivity (α=0.2, 0.3, and 0.4 /Gy), and different start time for repopulation (Tk=21, 28, and 35 days). Also the influence of age (≤50 years >), Hb level (≤116 g/l>), tumor proliferation rate (bromodeoxyuridine labelling index; BrdUrdLI), and DNA ploidy on survival after shorter (≤60 days) or longer (>60 days) OTT was investigated. The study included 229 patients with cervix carcinoma treated entirely by standard radiotherapy (RT) (external beam RT plus low-medium dose-rate (LDR/MDR) brachytherapy (BT) at the Center of Oncology in Krakow. The linear quadratic equation was used to calculate BED, which is proportional to log cell kill. BEDs 10 (for tumours) were calculated with consideration of OTT for each patient and tumour proliferation rate (standardized potential doubling time; standardized Tpot) based on BrdUrdLI assessed on biopsy material before RT. Median OTT was 90 days (range 30–210). The mean calculated total BED for point A for tumour and ‘early reactions’ was equal to 103.0 Gy10. The longest median survival time—52 months—was seen for patients treated with OTT ≤60 days. If OTT exceeded 90 days to more than 120 days, loss in BED10 for relatively radiosensitive tumours (α=0.3–0.4/Gy and Tk=28 days) was equal to 0.37–0.26 Gy/day. However, for radioresistant tumours (α=0.2/Gy) it was 0.6 Gy/day. For fast proliferating tumours (BrdUrdLI >8.8%) BED loss was 1.4 Gy/day and for slowly proliferating tumours (BrdUrdLI ≤8.8%) it was 0.2 Gy/day. Assuming shorter (21 days) or longer (35 days) periods for Tk and relatively radiosensitive tumours similar BED loss of 0.38 Gy/day was observed. Kaplan–Meier analysis revealed that OTT ≤60 days was a significant prognostic factor for overall survival (OS) (p=0.019), disease-free survival (DFS) (p=0.0173), and local control (LC) (p=0.011). BED10 had significant influence on survival (p=0.047). Cox multivariate analysis revealed that for OTT shorter than 60 days the only favourable significant parameters were: age >50 years (p=0.003) and high Hb level (>116 g/l) (p=0.041). For longer treatments (OTT >60 days) the unfavourable parameters were: age ≤50 years (p=0.037), BrdUrdLI ≤8.8% (p=0.003), tumour aneuploidy (p=0.043), and BED10 ≤103 Gy (p=0.017). The examined tumour biological parameters should be taken into account for RT and provide a basis for adjuvant RT.

[1]  G. Wilson A New Look at Proliferation , 2001, Acta oncologica.

[2]  K. Trott,et al.  The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. , 1981, International journal of radiation oncology, biology, physics.

[3]  J. Fowler,et al.  The adverse effect of treatment prolongation in cervical carcinoma. , 1995, International journal of radiation oncology, biology, physics.

[4]  R. Dale,et al.  The clinical radiobiology of brachytherapy. , 1998, The British journal of radiology.

[5]  G. Wilson,et al.  Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  A. Gerbaulet,et al.  Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. , 1993, International journal of radiation oncology, biology, physics.

[7]  A. Gerbaulet,et al.  HDR versus LDR gynecological brachytherapy revisited. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  A. Fyles,et al.  The effect of treatment duration in the local control of cervix cancer. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  H. Withers,et al.  Four R's of radiotherapy , 1975 .

[10]  B. O'Sullivan,et al.  The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix , 1992 .

[11]  J. Fowler The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.

[12]  S. Stringer,et al.  An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. , 1997, International journal of radiation oncology, biology, physics.

[13]  J C Horiot,et al.  The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  T. Pajak,et al.  The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. , 1993, International journal of radiation oncology, biology, physics.

[15]  J. Fowler,et al.  Dose reduction factors when increasing dose rate in LDR or MDR brachytherapy of carcinoma of the cervix. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  B. Maciejewski,et al.  Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  B. Lord,et al.  Growth Kinetics of Tumours , 1978, British Journal of Cancer.

[18]  C. West,et al.  Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. , 1995, The British journal of radiology.

[19]  J. M. Taylor,et al.  The hazard of accelerated tumor clonogen repopulation during radiotherapy. , 1988, Acta oncologica.

[20]  R. Tsang,et al.  Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  J. Fowler,et al.  Biologically effective doses in radiotherapy of cervical carcinoma*. , 2004, Neoplasma.

[22]  H. Thames,et al.  Has the influence of treatment duration on local control of carcinoma of the cervix been defined? , 1995, International journal of radiation oncology, biology, physics.

[23]  D.,et al.  Regression Models and Life-Tables , 2022 .

[24]  Anders Brahme,et al.  Prognostic Significance of Intratumour Microvessel Density and Haemoglobin Level in Carcinoma of the Uterine Cervix , 2002, Acta oncologica.

[25]  M. Lindstrom,et al.  Loss of local control with prolongation in radiotherapy. , 1992, International journal of radiation oncology, biology, physics.

[26]  Limitations of the Bromodeoxyuridine Technique for Measurement of Tumour Proliferation , 1993 .

[27]  J. Salvajoli,et al.  High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. , 2001, International journal of radiation oncology, biology, physics.

[28]  P. Grigsby,et al.  Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[29]  J. Hendry,et al.  The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[31]  J. Denekamp Changes in the rate of repopulation during multifraction irradiation of mouse skin. , 1973, The British journal of radiology.

[32]  G. Barendsen,et al.  Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. , 1982, International journal of radiation oncology, biology, physics.

[33]  G. Kerr,et al.  The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  J. Fowler,et al.  Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? , 1986, International journal of radiation oncology, biology, physics.

[35]  B. Jones,et al.  Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy. , 1996, The British journal of radiology.

[36]  J F Fowler,et al.  Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.